Incidence and long-term prognosis of papillary renal cancer: Results of a retrospective multicenter study;Inzidenz und Langzeitprognose des papillären Nierenzellkarzinoms: Ergebnisse einer retrospektiven Multicenterstudie

Urologe - Ausgabe A

Volumn 50, Issue 9, 2011, Pages 1125-1129

  Waalkes, S ^a   Roos, F C ^b   Eggers, H ^a   Schumacher, S ^c   Janssen, M ^d   Wegener, G ^a   Thuroff J W ^b   Hofmann, R ^e   Schrader, M ^c   Kuczyk, M A ^a   Schrader, A J ^c,e  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Clear cell kidney cancer; Papillary renal cell carcinoma; Papillary subtype; Prognosis; Risk factors

Indexed keywords

ADVANCED CANCER; AGE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CLEAR CELL CARCINOMA; CLEAR CELL RENAL CELL CARCINOMA; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PAPILLARY RENAL CELL CARCINOMA; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 80755172270     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-011-2684-6     Document Type: Article

References (29)

1. Schrader AJ, Varga Z, Hegele A et al (2006) Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. J Cancer Res Clin Oncol 132:137-149 (Pubitemid 43015774)
2. Motzer RJ, Bacik J, Mariani T et al (2002) Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology. J Clin Oncol 20:2376-2381 (Pubitemid 34441667)
3. Herrmann E, Brinkmann OA, Bode ME et al (2007) Treatment of metastatic papillary renal cell carcinoma with immunochemotherapy with interleu-kin-2, interferon-alpha and 5-fluorouracil. J Clin Oncol 25:15644
4. Schmidt L, Duh FM, Chen F et al (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16:68-73 (Pubitemid 27198158)
5. Sweeney P, El-Naggar AK, Lin SH, Pisters LL (2002) Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol 168:51-55 (Pubitemid 34640783)
6. Linehan WM, Vasselli J, Srinivasan R et al (2004) Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res 10:6282-6289
7. Linehan WM, Walther MM, Zbar B (2003) The genetic basis of cancer of the kidney. J Urol 170:2163-2172 (Pubitemid 37413950)
8. Lin ZH, Han EM, Lee ES et al (2004) A distinct expression pattern and point mutation of c-kit in papillary renal cell carcinomas. Mod Pathol 17:611-616 (Pubitemid 38715481)
9. Schrader AJ, Varga Z, Pfoertner S et al (2006) Treatment targeted at vascular endothelial growth factor: a promising approach to managing metastatic kidney cancer. BJU Int 97:461-465
10. Schrader AJ, Rauer-Bruening S, Olbert PJ et al (2009) Incidence and long-term prognosis of papillary renal cell carcinoma. J Cancer Res Clin Oncol 135:799-805
11. Patard JJ, Leray E, Rioux-Leclercq N et al (2005) Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23:2763-2771 (Pubitemid 46179466)
12. Steiner T, Roigas J, Kirchner H et al (2006) Clinical course of patients with metastatic papillary renal cell carcinoma. J Clin Oncol 24:14591
13. Schrader AJ, Olbert PJ, Hegele A et al (2008) Metastatic non-clear cell renal cell carcinoma: current therapeutic options. BJU Int 30:1343-1345 (Pubitemid 351623979)
14. Storkel S, Eble JN, Adlakha K et al (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:987-989
15. Cheville JC, Lohse CM, Zincke H et al (2003) Comparisons of outcomeand prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612-624 (Pubitemid 36514472)
16. Mancilla-Jimenez R, Stanley RJ, Blath RA (1976) Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38:2469-2480 (Pubitemid 8015883)
17. Kim H, Cho NH, Kim DS et al (2004) Renal cell carcinoma in South Korea: a multicenter study. Hum Pathol 35:1556-1563 (Pubitemid 40017998)
18. Amin MB, Tamboli P, Javidan J et al (2002) Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol 26:281-291 (Pubitemid 34184451)
19. Gudbjartsson T, Hardarson S, Petursdottir V et al (2005) Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 48:593-600 (Pubitemid 41278584)
20. Margulis V, Tamboli P, Matin SF et al (2008) Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 112:1480-1488 (Pubitemid 351441160)
21. Ljungberg B, Alamdari FI, Stenling R, Roos G (1999) Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol 36:565-569 (Pubitemid 29516286)
22. Delahunt B, Eble JN (1997) Papillary renal cell carcinoma: a clinicopathologic and immunohistoche-mical study of 105 tumors. Mod Pathol 10:537-544 (Pubitemid 27293491)
23. Mejean A, Hopirtean V, Bazin JP et al (2003) Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 170:764-767 (Pubitemid 36999550)
24. Pignot G, Elie C, Conquy S et al (2007) Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 sub-classification. Urology 69:230-235 (Pubitemid 46274917)
25. Delahunt B, Bethwaite PB, Nacey JN (2007) Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 39:459-465 (Pubitemid 47450591)
26. Yang XJ, Tan MH, Kim HL et al (2005) A molecular classification of papillary renal cell carcinoma. Cancer Res 65:5628-5637 (Pubitemid 40911163)
27. Wunderlich H, Schlichter A, Zermann D et al (1999) Multifocality in renal cell carcinoma: A bilateral event? Urol Int 63:160-163 (Pubitemid 30083820)
28. Klatte T, Patard JJ, Wunderlich H et al (2007) Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol 177:2081-2086
29. Krambeck A, Iwaszko M, Leibovich B et al (2008) Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int 101:1375-1379 (Pubitemid 351623988)